Prophylactic Intravenous Antibiotic Use in Thyroglossal Duct and Branchial Cleft Cyst Excision: A NSQIP‐P Analysis
Open Access
- 3 March 2026
- journal article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (5) , 1243-1252
Abstract
Objective: To identify patterns in prophylactic intravenous antibiotics (PIAB) usage for thyroglossal duct and branchial cleft cyst excisions, and to evaluate whether PIAB improve patient outcomes. Study Design: Retrospective cohort study. Setting: American College of Surgeons National Surgical Quality Improvement Program‐Pediatric (NSQIP‐P) Surgical Antibiotic Prophylaxis Database. Methods: The NSQIP‐P database was queried for pediatric patients (≤18) from 2021 to 2023 who underwent thyroglossal duct or branchial cleft cyst excision. Multivariate regressions assessed associations between PIAB use and outcomes including surgical site infection, unplanned readmission, and reoperation while adjusting for clinicodemographic factors (age, sex, race/ethnicity, admission status, surgical specialty, ASA classification, and wound classification). Results: Of 2106 TGDC and 2837 BCC patients, 83.5% and 68.0% received PIAB, respectively. Hispanic ethnicity, postoperative admission, and clean‐contaminated wound classification were associated with increased PIAB use in both groups. In BCC patients, younger age and treatment by non‐otolaryngologists predicted decreased PIAB use. While univariate analysis in TGDC cases showed lower infection rates with PIAB (OR, 0.52; 95% CI, 0.30‐0.95; P = .025), this was not significant on multivariate analysis (0.59, 0.34‐1.08, P = .074). PIAB did not significantly affect infection, readmission, or reoperation rates in either cohort on multivariate analysis. Conclusion: PIAB use in pediatric TGDC and BCC excisions varies with clinicodemographic factors but did not consistently reduce adverse outcomes. These findings underscore the need to reevaluate the necessity of PIAB and encourage further investigations to develop evidence‐based guidelines for pediatric neck mass surgery.Keywords
This publication has 26 references indexed in Scilit:
- Antibiotic stewardship in pediatric head and neck surgeryInternational Journal of Pediatric Otorhinolaryngology, 2025
- Age-related outcomes after pediatric branchial cleft cyst excision via NSQIP-PInternational Journal of Pediatric Otorhinolaryngology, 2023
- Liberal or restrictive antimicrobial prophylaxis for surgical site infection: systematic review and meta-analysis of randomised trialsBritish Journal of Anaesthesia, 2022
- Pediatric thyroglossal duct cyst excision: A NSQIP-P analysis of 30-day complicationsInternational Journal of Pediatric Otorhinolaryngology, 2021
- Current trends and 30-day surgical outcomes for thyroglossal duct cyst excision in childrenInternational Journal of Pediatric Otorhinolaryngology, 2020
- Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse EventsJAMA Surgery, 2019
- A cross-sectional evaluation of outcomes of pediatric branchial cleft cyst excisionInternational Journal of Pediatric Otorhinolaryngology, 2019
- Sublingual thyroglossal duct cyst (SLTGDC): An unusual locationJournal of Pediatric Surgery Case Reports, 2016
- Thyroglossal duct surgery. Sistrunk procedureEuropean Annals of Otorhinolaryngology, Head and Neck Diseases, 2016
- Timing of Surgical Antibiotic Prophylaxis and the Risk of Surgical Site InfectionJAMA Surgery, 2013